Core Viewpoint - 中核国际 reported a significant increase in revenue and profit for the first half of 2025, primarily driven by a surge in uranium trading activities [1][2] Financial Performance - The company recorded a revenue of approximately HKD 592 million, representing a massive increase of about 9152% compared to the same period in 2024, where revenue was around HKD 6.4 million [1] - Gross profit increased by approximately 207% to about HKD 19.67 million, compared to HKD 6.4 million in the same period last year [1] - The company turned a pre-tax profit of approximately HKD 12.37 million, compared to a pre-tax loss of about HKD 6.12 million in 2024 [1] - Net profit for the period was approximately HKD 10.36 million, reversing from a net loss of about HKD 7.73 million in the previous year [1] Uranium Trading Activities - The company sold approximately 220,000 pounds of natural uranium, generating revenue of about HKD 592 million [2] - Revenue from uranium trading included approximately 1 million pounds sold through independent third-party transactions, and around 530,000 pounds and 750,000 pounds sold to 中核集团 through uranium supply and agency transactions, respectively [2] - The company facilitated the trade of about 450,000 pounds of natural uranium through uranium procurement transactions related to the 罗辛铀矿, in which it holds a 68.62% indirect interest [2] - The majority of the revenue, approximately HKD 582 million, came from transactions with independent third parties, attributed to stable spot uranium prices during the review period [2]

Core Viewpoint - 中核国际 (02302) reported a significant increase in revenue and a turnaround in profit for the six months ending June 30, 2025, primarily driven by a surge in uranium trading activities [1] Financial Performance - Revenue reached HKD 592 million, representing a year-on-year increase of 9151.72% [1] - Shareholders' profit amounted to HKD 10.359 million, compared to a loss of HKD 7.731 million in the same period last year, indicating a successful turnaround [1] - Basic earnings per share were HKD 0.0212 [1] Business Operations - The substantial revenue growth was mainly attributed to a significant increase in the trading volume of uranium, with approximately HKD 582 million of revenue generated from transactions involving natural uranium sold to independent third parties [1]

Core Viewpoint - China Nuclear International (02302) reported a significant increase in revenue and a turnaround in profit for the six months ending June 30, 2025, primarily driven by a surge in uranium trading volume [1] Financial Performance - Revenue reached HKD 592 million, representing a year-on-year increase of 9151.72% [1] - Shareholders' profit amounted to HKD 10.359 million, compared to a loss of HKD 7.731 million in the same period last year, indicating a successful turnaround [1] - Basic earnings per share were HKD 0.0212 [1] Business Operations - The substantial revenue growth was mainly attributed to the significant increase in the group's uranium trading business [1] - Approximately HKD 582 million of the total revenue was generated from transactions involving the sale of natural uranium to independent third parties [1]

Group 1 - The company, China Nuclear International (02302), announced a general financing agreement with China Nuclear Finance Management Co., Ltd. [1] - Under this agreement, China Nuclear Finance will provide up to $50 million in committed financing for the company's uranium trading business [1]

格隆汇8月21日丨中核国际(02302.HK)公告，于2025年8月21日，公司与中核财资管理有限公司("中核财 资")订立一般融资协议，据此，中核财资会向公司提供高达5000万美元的已承诺融资，用于集团铀贸易 业务。 ...

Core Viewpoint - 中核国际预计2025年半年度收入将显著增长，毛利和净利润也将实现大幅改善 [1] Financial Performance - 预计2025年半年度收入将达到不少于5.85亿港元，毛利将不少于1300万港元 [1] - 2024年同期收入和毛利分别为约640万港元 [1] - 预计2025年半年度股东应占净利润将不少于950万港元，扭转2024年半年度的净亏损约770万港元 [1] Business Growth Drivers - 收入增长主要得益于铀贸易业务交易量的大幅增加，绝大部分收入来自与独立第三方的天然铀贸易 [1] - 由于2024年下半年及2025年半年度现货铀价格相对稳定，集团能够在风险可控的前提下增加铀贸易业务 [1]

Group 1 - The core viewpoint of the article highlights that China Nuclear International (02302) has experienced a significant stock price increase of over 5%, currently trading at 3.9 HKD with a transaction volume of 1.6637 million HKD [1] - The company anticipates a substantial increase in revenue for the first half of 2025, projecting it to reach at least approximately 585 million HKD, compared to around 64 million HKD for the same period in 2024 [1] - The gross profit for the first half of 2025 is expected to rise to at least approximately 13 million HKD, a significant increase from the gross profit of around 640,000 HKD in the first half of 2024 [1] Group 2 - The company forecasts a turnaround from a net loss attributable to shareholders of approximately 7.7 million HKD in the first half of 2024 to a net profit of at least approximately 9.5 million HKD in the first half of 2025 [1] - This performance improvement is primarily attributed to a substantial increase in the trading volume of uranium business, with most revenue derived from natural uranium trading with independent third parties [1] - The stability of spot uranium prices in the second half of 2024 and the first half of 2025 has allowed the company to expand its uranium trading business with independent third parties while maintaining controllable risks [1]

智通财经APP讯，中核国际(02302)发布公告，预期集团于2025年半年度的收入将大幅增加至不少于约 5.85亿港元，2025年半年度的毛利增加至不少于约1300万港元，而2024年同期取得的收入及毛利均为约 640万港元(按净额基准确认销售代理收入)。同时，由2024年半年度股东应占净亏损约770万港元扭转为 2025年半年度股东应占净利润不少于约950万港元。 2025年半年度股东应占净利润由2024年半年度的股东应占净亏损转为2025年半年度的股东应占净利润， 主要由于集团铀贸易业务交易量大幅增加使毛利大幅增加不少于约港币1300万元及银行利息收入增加不 少于约港币300万元。另一方面，由于集团于2024年下半年出售一间附属公司的权益，集团于2025年半 年度不再享有联营公司的任何收益份额(2024年半年度享有的联营公司收益约港币1560万元)。此外，由 于集团于2025年半年度并无动用任何银行融资，财务费用较2024年半年度减少不少于约港币1300万元。 集团2025年半年度收入大幅上涨，并由2024年半年度净亏损转为归属于股东的净利润，主要得益于集团 铀贸易业务交易量的大幅增长，其中绝大部分收入来 ...

2025年半年度股东应占净利润由2024年半年度的股东应占净亏损转为2025年半年度的股东应占净利润， 主要由于集团铀贸易业务交易量大幅增加使毛利大幅增加不少于约港币1,300万元及银行利息收入增加 不少于约港币300万元。另一方面，由于集团于2024年下半年出售一间附属公司的权益，集团于2025年 半年度不再享有联营公司的任何收益份额(2024年半年度享有的联营公司收益约港币1,560万元)。此外， 由于集团于2025年半年度并无动用任何银行融资，财务费用较2024年半年度减少不少于约港币1,300万 元。 格隆汇7月31日丨中核国际(02302.HK)发布公告，预期集团于2025年半年度的收入将大幅增加至不少于 约港币5.85亿元，2025年半年度的毛利增加至不少于约港币1,300万元，而2024年同期("2024年半年度") 录得的收入及毛利均为约港币640万元(按净额基准确认销售代理收入)。同时，由2024年半年度股东应 占净亏损约港币770万元扭转为2025年半年度股东应占净利润不少于约港币950万元。 集团2025年半年度收入大幅上涨，并由2024年半年度净亏损转为归属于股东的净利润，主要得益于集 ...

2025年半年度股东应占净利润由2024年半年度的股东应占净亏损转为2025年半年度的股东应占净利润， 主要由于集团铀贸易业务交易量大幅增加使毛利大幅增加不少于约港币1300万元及银行利息收入增加不 少于约港币300万元。另一方面，由于集团于2024年下半年出售一间附属公司的权益，集团于2025年半 年度不再享有联营公司的任何收益份额(2024年半年度享有的联营公司收益约港币1560万元)。此外，由 于集团于2025年半年度并无动用任何银行融资，财务费用较2024年半年度减少不少于约港币1300万元。 中核国际(02302)发布公告，预期集团于2025年半年度的收入将大幅增加至不少于约5.85亿港元，2025年 半年度的毛利增加至不少于约1300万港元，而2024年同期取得的收入及毛利均为约640万港元(按净额基 准确认销售代理收入)。同时，由2024年半年度股东应占净亏损约770万港元扭转为2025年半年度股东应 占净利润不少于约950万港元。 集团2025年半年度收入大幅上涨，并由2024年半年度净亏损转为归属于股东的净利润，主要得益于集团 铀贸易业务交易量的大幅增长，其中绝大部分收入来自与独立第三方之间 ...